HPGDS and renal fibrosis: In renal settings, while in vitro PGD2 played an anti-fibrogenic role by suppressing the induction of fibrotic phenotype in cultured kidney cells [24,25]; in vivo, PGD2 emerged as pro-fibrogenic since DP2 antagonism downregulates renal fibrosis in a chronic model of kidney inflammation [26].